Professor of Surgery, Mayo Medical School
General Surgery
Dr. David M. Nagorney, MD
|
|
Give Review
Dr. David M. Nagorney is an expert in the field of General Surgery. He went to University of Kansas School of Medicine. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer" and "Fellow (FACS)". David M. Nagorney, MD is also a published doctor. He has 101 publication published. The most recent publication is: Metabolic Syndrome is Associated with Increased Postoperative Morbidity and Hospital Resource Utilization in Patients Undergoing Elective Pancreatectomy. David Nagorney accepts Medicare payments and is registered with Medicare.gov.
Publications
- A NSQIP Review of Major Morbidity and Mortality of Synchronous Liver Resection for ColoRectal Metastasis Stratified by Extent of Liver Resection and Type of ColoRectal...
- Metabolic Syndrome is Associated with Increased Postoperative Morbidity and Hospital Resource Utilization in Patients Undergoing Elective Pancreatectomy.
- Surgical treatment of hepatocellular Carcinoma in north america: can hepatic resection still be justified?
- Unique genomic profile of fibrolamellar hepatocellular Carcinoma.
- Operative interventions for extrahepatic porto-mesenteric venous aneurysms and long-term outcomes.
- Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre Analysis.
- Surgical resection of synchronously metastatic adrenocortical Cancer.
- Necrotic ulcerations after splenectomy.
- Model to predict survival after surgical resection of intrahepatic cholangioCarcinoma: the Mayo Clinic experience.
- Pancreaticoduodenectomy with Major Vascular Resection: a Comparison of Laparoscopic Versus Open Approaches.
- Defining Perioperative Risk after Hepatectomy Based on Diagnosis and Extent of Resection.
- Hilar CholangioCarcinoma.
- Management of Biliary Cystic Tumors: A Multi-institutional Analysis of a Rare Liver Tumor.
- Portal Venous Thrombosis After Distal Pancreatectomy: Clinical Outcomes.
- What is the Role of Bone Marrow-Derived Stem Cells in Hepatic Hypertrophy After Portal Vein Embolization?
- Modern Chemotherapy Mitigates Adverse Prognostic Effect of Regional Nodal Metastases in Stage IV Colorectal Cancer.
- Correlation of staging systems to survival in patients with resected hilar cholangioCarcinoma.
- Microvascular Invasion Does Not Predict Long-Term Survival in Hepatocellular Carcinoma up to 2Â cm: Reappraisal of the Staging System for Solitary Tumors.
- Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors.
- Adjunctive radiofrequency ablation of metastatic neuroendocrine Cancer to the liver complements surgical resection.
- Improved Long-Term Survival after Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy.
- Role of Major Vascular Resection in Patients with Intrahepatic CholangioCarcinoma.
- ERCP for the treatment of Bile leak after partial hepatectomy and fenestration for symptomatic polycystic liver disease.
- Role of operative therapy in treatment of metastatic gastroIntestinal stromal tumors.
- Resection of a giant primary synovial sarcoma of the inferior vena cava extending into the right atrium with caval reconstruction under cardiopulmonary bypass and circ...
- Adjuvant hepatic arterial infusional chemotherapy: revisiting the past or a new era?
- Frequency of Subtypes of Biliary IntraDuctal Papillary Mucinous Neoplasm and Their MUC1, MUC2, and DPC4 Expression Patterns Differ from Pancreatic IntraDuctal Papillar...
- Neoadjuvant Treatment of Duodenal AdenoCarcinoma: A Rescue Strategy.
- Synchronous Rectal and Hepatic Resection of Rectal Metastatic Disease.
- Hepatic Arterial Infusion and Systemic Chemotherapy After Multiple Metastasectomy in Patients With Colorectal Carcinoma Metastatic to the Liver: A North Central Cancer...
- Patterns of pancreatic resection differ between patients with familial and sporadic pancreatic Cancer.
- Hepatic Resection for the Carcinoid Syndrome in Patients with Severe Carcinoid Heart Disease: Does Valve Replacement Permit Safe Hepatic Resection?
- Diagnosis and Treatment of Mirizzi Syndrome: 23-Year Mayo Clinic Experience.
- Resection and Fenestration for Symptomatic Polycystic Liver Disease.
- miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular Carcinoma cell lines.
- Management of giant hemangioma of the Liver: resection versus observation.
- Medical and surgical treatment options for polycystic liver Disease.
- Is there a role for endoscopic therapy as a definitive treatment for post-laparoscopic Bile duct injuries?
- Resection of the inferior vena cava for an isolated para-aortic recurrence of endometrial Cancer: report of a case.
- Laparoscopic vs open distal pancreatectomy: a single-institution comparative study.
- Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center Analysis.
- The impact of hepatic venous anatomy on the hepatic remnant: need for assessment?
- Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal Cancer: a North Central Cancer Treatment Group (NCCTG)/ National...
- Pancreatoduodenectomy for Ductal adenocarcinoma: implications of positive margin on survival.
- The international position on laparoscopic Liver surgery: The Louisville Statement, 2008.
- Impact of neoadjuvant chemotherapy with FOLFOX/FOLFIRI on disease-free and overall survival of patients with coloRectal metastases.
- Splenic salvage after intraoperative splenic injury during colectomy.
- Adjuvant therapy for gallbladder Carcinoma: the Mayo Clinic Experience.
- Improved survival in metastatic colorectal Cancer is associated with adoption of hepatic resection and improved chemotherapy.
- Polycystic liver Disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation.
- Bile duct cysts: contemporary surgical management.
- Transplantation for cholangioCarcinoma: when and for whom?
- Peritumoral steatosis associated with insulinomas: appearance at imaging.
- Adjuvant radiotherapy and chemotherapy for pancreatic Carcinoma: the Mayo Clinic experience (1975-2005).
- Experience with 208 resections for intraDuctal papillary mucinous neoplasm of the pancreas.
- Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular Carcinoma.
- Duodenocaval fistula after irradiation and resection of a retroperitoneal sarcoma.
- Selection for resection of hepatocellular Carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resec...
- Long-term survival after pancreatoduodenectomy for pancreatic adenoCarcinoma: is cure possible?
- Role of hepatic resection for patients with carcinoid heart Disease.
- Association of MicroRNA expression in hepatocellular Carcinomas with hepatitis infection, cirrhosis, and patient survival.
- Inferior vena cava stenting: a safe and effective treatment for intractable ascites in patients with polycystic liver Disease.
- Hepatic resection for coloRectal metastases: value for risk scoring systems?
- Outcomes of primary liver Cancer in children: an appraisal of experience.
- Right hepatectomy for living liver donation vs right hepatectomy for Disease: intraoperative and immediate postoperative comparison.
- Risk factors for mortality after surgery in patients with cirrhosis.
- The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular Carcinoma: evaluation in a United States referral population.
- Predictive indices of morbidity and mortality after Liver resection.
- Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and Biliary malignancies?
- Liver transplantation for gastroenteropancreatic neuroendocrine Cancers: Defining selection criteria to improve survival.
- Hepatic surgery for metastatic gastroIntestinal neuroendocrine tumors.
- Hepatic resection in the treatment of hilar cholangioCarcinoma.
- Hepatic resection for noncoloRectal, nonneuroendocrine metastases.
- Hepatic resection of hepatocellular Carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.
- Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?
- Staging of hepatocellular Carcinoma.
- Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangioCarcinoma.
- Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular Carcinoma.
- Distal pancreatectomy for resectable adenoCarcinoma of the body and tail of the pancreas.
- Hepatectomy for hepatocellular Carcinoma with major portal or hepatic vein invasion: results of a multicenter study.
- Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation.
- Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular Carcinoma.
- The role of defective mismatch repair in small bowel adenoCarcinoma in celiac disease.
- A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant Bile duct strictures.
- Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus.
- Concurrent vs. staged colectomy and hepatectomy for primary colorectal Cancer with synchronous hepatic metastases.
- Major hepatic resection for hilar cholangiocarcinoma: Analysis of 46 patients.
- Quality-of-life assessment of surgical reconstruction after laparoscopic cholecystectomy-induced Bile duct injuries: what happens at 5 years and beyond?
- The spleen in myelofibrosis with myeloid metaplasia.
- Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience.
- Risk factors for early death due to recurrence after liver resection for hepatocellular Carcinoma: results of a multicenter study.
- hSulf1 Sulfatase promotes apoptosis of hepatocellular Cancer cells by decreasing heparin-binding growth factor signaling.
- Surgical treatment of gallbladder Cancer.
- Iatrogenic hepatic artery pseudoaneurysms: an uncommon complication after hepatic, Biliary, and pancreatic procedures.
- Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular Carcinoma treated in the United States, France, and Japan.
- Intraoperative electron radiotherapy as a component of salvage therapy for patients with colorectal Cancer and advanced nodal metastases.
- Open versus laparoscopic splenectomy for idiopathic thrombocytopenic purpura: clinical and economic Analysis.
- Surgical treatment of neuroendocrine metastases to the Liver: a plea for resection to increase survival.
- Is combined partial hepatectomy with segmental resection of inferior vena cava justified for malignancy?
- Successful endoscopic treatment of a complete transection of the Bile duct complicating laparoscopic cholecystectomy.
Schools
University of Kansas School of Medicine
Mayo Clinic Rochester
Procedures Preformed
- Adrenalectomy
- Appendectomy, Open
- Biliary Drainage
- Colectomy
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- AnoRectal Abscess
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Fellow (FACS)
Education
-
Mayo School of Graduate Medical Education -
University of Kansas School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447238886 |
| Last Name Of The Provider | NAGORNEY |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Santhat Nivatvongs, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rushin D. Brahmbhatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kamran M. Karimi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan A. Helmick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daaron A. McField, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin M. Kemp, MD |
|
|
Dr. Rizwan M. Chaudhry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Williams, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin Zendejas-Mummert, MD |
|
|
Aodhnait S. Fahy, MB CHB |